Title : EGFR Mutations and Resistance to Irreversible Pyrimidine-Based EGFR Inhibitors.

Pub. Date : 2015 Sep 1

PMID : 25948633






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Cells containing an EGFR-sensitizing mutation, Del 19 or L858R, in conjunction with L718Q, L844V, or C797S retain sensitivity to quinazoline-based EGFR inhibitors, gefitinib and afatinib. Quinazolines epidermal growth factor receptor Homo sapiens
2 Cells containing an EGFR-sensitizing mutation, Del 19 or L858R, in conjunction with L718Q, L844V, or C797S retain sensitivity to quinazoline-based EGFR inhibitors, gefitinib and afatinib. Quinazolines epidermal growth factor receptor Homo sapiens